% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

  • xpac290ea xpac290ea Jul 24, 2012 4:31 PM Flag

    Zertane Data?!?

    Does anyone have an idea of when data from the Zertane trials are supposed to come out? There also is not much data available from the previous trials, I have dealt with some other Biotechs that usually have some information on which can be very helpful.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I am sitting on over 140,000 shares. Been long for a very long time. I didn't sell at $8, and don't plan on selling until it is well over that. Based on the science I don't think that will be an issue. Ampion-in-knee is just scratching the surface of Ampion's applications -merely the low hanging fruit in what I think will be the next wonder drug. And it's only one part of the pipeline. This can truly be a remarkable story - and it sure make my day!!

      Sentiment: Strong Buy

      • 1 Reply to th3k33p3r24
      • I believe very strongly that you will become exceedingly wealthy with your position if you can hold it without being shaken out on the way up.. So far you have done a remarkable job of holding through the last years roller coaster ride. I interviewed Dr. Bar-Or and learned about the mechanism underlying NCE001. I am going on record as stating that NCE001 will be the most powerful cancer fighting drug in history. Ampion will also be a miracle drug that will eventually dominate the 60 billion dollar anti-inflmmatory market. Optina and Vasaloc are going to be huge because they work so well and have no side effects and the market is large and growing rapidly. And Zertane will be the SuperSex drug of the century.

        Well done!!!!!

    • Maybe after the studies actually start?

      I wonder why this study:, was stopped because of recruitment difficulties?

    • yeah i checked as well and couldn't find any details on basic keywords like tramadol, sexual dysfunction, ampio and combinations of these etc. best of luck to you my friend.

      ps I am long AMPE with 5000+ shares.

      • 2 Replies to gsx1272
      • Ampio (AMPE) Will Proceed with Zertane Development Following Positive Pre-IND Meetings

        FREE Breaking News Alerts from!

        E-mail Address

        Top News Most Read Highlighted
        Dow Adds 80 Points to Rally as Draghi to Discuss New Possibilities for ECB Action
        Top 10 News Items 7/23-7/27: Apple Can't Win 'Em All; Facebook Investors Sell Despite Inline Results; Draghi Giving Markets Hope
        AT&T (T) Adds 300M Shares to Buyback Plan
        Another Tequila Weekend for Investors after Wild Week on Wall Street
        Apple (AAPL) Buys AuthenTec (AUTH) for About $356 Million
        OCZ Technology (OCZ) Jumps as Takeover Speculation Goes from a Dull Roar to a Growl
        With Rumors Swirling, OCZ Technology (OCZ) Cancels Next Week's Road Show
        Nokia (NOK) Trades Strong; Energized by Sector News, Euro Support (S) (AAPL) (VZ)
        Leerink Swann Lifts Target on Amarin (AMRN) After FDA Approval
        Gilford Securities Reiterates a 'Buy' on VirnetX Holding (VHC); Clearing Up Some Concerns, Events and Articles
        Analyst Says Alcatel (ALU) Faces Two-Headed Monster, Slashes Target to Zero
        Nokia (NOK) Trades Strong; Energized by Sector News, Euro Support (S) (AAPL) (VZ)
        Starbucks (SBUX) Q3 Results Pressure Green Mountain (GMCR), But Is the Sell Off Overdone?
        Higher Gold Prices (GLD) Provide Relief to Miners (GDX), But Issues Remain
        Though Coal Shipments are Down, CSX (CSX) Will Thrive - Cramer
        July 2, 2012 9:06 AM EDT
        Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), is proceeding with the development plan for a combination product to treat both premature ejaculation (PE) and erectile dysfunction (ED). The positive pre-IND meeting in June with the FDA gave the company clear guidance for the two concurrent pivotal trials necessary for approval of Zertane to treat PE in the USA.

        Vaughan Clift, MD, Ampio's Chief Regulatory Officer, noted "Contrary to rumors that the FDA did not recognize PE as a treatable ailment, the FDA has expressly adopted the definition of PE as a disease condition, using the definition of Premature Ejaculation provided by the International Society for Sexual Medicine (ISSM) Ad Hoc Committee (i.e., premature ejaculation is characterized by ejaculation which always or nearly always occurs prior to or within about one minute of vaginal penetration; and inability to delay ejaculation on all or nearly all vaginal penetrations; and negative personal consequences, such as distress, bother, frustration and/or the avoidance of sexual intimacy.*) This definition fully complements and encompasses the clinical results from its successful Phase 3 studies of Zertane™ conducted in Europe which was reported in the prestigious journal European Urology."

      • Thanks and best of luck to you too. I wish I had as much but I'm long 1250, although I'm looking to increase my position. I think we have a potential winner here. Someone brought up a great point, we are looking at four potential blockbuster drugs when most biotech's are just counting on one. The markets for these drugs are also well diversified within the industry and have a lot of market share that could be gained if all goes well with positive clinical data and FDA approvals. With the current float and the market cap this stock can squeeze hard due to all the shorts but I do believe that future value (5 yrs) will be in the billions yielding a pps of 50's -80's if not more. Best of Luck to All!!!

0.9571-0.0353(-3.56%)Jul 22 4:02 PMEDT